panther: apalutamide abiraterone in black and white mcrpc patients
Published 1 year ago • 247 plays • Length 1:20Download video MP4
Download video MP3
Similar videos
-
5:59
apalutamide in combination with abiraterone acetate, docetaxel and prednisone for mcrpc
-
1:52
treatment sequencing in mcrpc: cabazitaxel vs. abiraterone or enzalutamide
-
10:00
results from acis trial of apalutamide abiraterone/prednisone in patients with chemo-naive mcrpc
-
4:18
acis trial of apalutamide and abiraterone in chemotherapy-naïve mcrpc
-
2:13
head-to-head: tolerability of enzalutamide vs. abiraterone acetate for metastatic crpc
-
1:55
awaiting key results for enzalutamide and apalutamide in nmcrpc
-
2:34
first-line treatments for patients with mhspc and mcrpc
-
1:22
cabazitaxel improves rpfs in patients with mcrpc
-
31:13
titan trial | investigating the addition of apalutamide to androgen deprivation therapy
-
16:30
how metabolic therapy checkmates cancer
-
5:19
xtandi patient stories
-
4:36
nonmetastatic crpc: considerations for apalutamide
-
8:12
the use of abiraterone and enzalutamide against crpc
-
2:04
a phase ii trial investigating neoadjuvant abiraterone and cabazitaxel in high-risk prostate cancer
-
1:30
bmi and clinical outcomes in patients with metastatic castration-resistant prostate cancer
-
2:05
startar: adt with apalutamide, radiation therapy and docetaxel in prostate cancer
-
0:54
convincing long-term survival with abiraterone in mcrpc
-
8:21
ep. 10: how has the mcrpc treatment landscape changed?
-
18:57
disease management for mcrpc
-
2:05
abiraterone in metastatic castration-sensitive prostate cancer
-
7:58
abiraterone and chemotherapy in crpc
-
2:59
niraparib and abiraterone acetate for metastatic castration-resistant prostate cancer